pharmaceuticals
pharmaceuticals Articles
Viagra, the wildly successful erectile dysfunction pill, faces challenges from a generic version that will launch next year.
Published:
Last Updated:
Juno Therapeutics saw its shares sink early on Friday after the U.S. Food and Drug Administration (FDA) levied a clinical hold on its leukemia treatment.
Published:
Last Updated:
Shares of Eleven Biotherapeutics saw a handy gain early on Friday after the company announced that its Investigational New Drug application for EBI-031 has become effective.
Published:
Last Updated:
PTC Therapeutics made waves on Thursday following a development in its nonsense mutation Duchenne muscular dystrophy (nmDMD) treatment.
Published:
Last Updated:
Flexion Therapeutics has announced that three new executives have joined the company in key marketing, medical affairs and market access roles.
Published:
Last Updated:
The broad markets are recovering in the wake of the Brexit and it really appears to be one big head fake. We are also realizing that the Brexit was a great opportunity to buy into the markets and...
Published:
Last Updated:
Array BioPharma Inc. (NASDAQ: ARRY) is watching its shares make a handy gain on Friday after making a key U.S. Food and Drug Administration (FDA) submission. The company announced the submission of a...
Published:
Last Updated:
Ampio Pharmaceuticals, Inc. (NYSEMKT: AMPE) is watching its shares get cut in half on Thursday after news of a failed late-stage trial. The company announced the results of its Ampion PIVOT clinical...
Published:
Last Updated:
Lipocine Inc. (NASDAQ: LPCN) is watching its shares get cut in half in Wednesday’s session after receiving a letter from the U.S. Food and Drug Administration (FDA). The company announced that it...
Published:
Last Updated:
Galena Biopharma, Inc. (NASDAQ: GALE) is absolutely crashing on Wednesday after the company released further information regarding its Breast Cancer clinical trial. The company announced the...
Published:
Last Updated:
Eli Lilly and Co. (NYSE: LLY) is watching its shares make a decent gain on Wednesday following a U.S. Food and Drug Administration (FDA) vote. The FDA Advisory Committee voted 12-11 that substantial...
Published:
Last Updated:
Sometimes market volatility and outside shocks create a rift between market prices and real value. That may currently be the case in the largest stocks in the biotech sector within health care if...
Published:
Last Updated:
inVentiv Group Holdings filed an amended Form S-1 with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were mentioned in this filing,...
Published:
Last Updated:
Regulus Therapeutics Inc. (NASDAQ: RGLS) saw its shares cut in half early Tuesday morning following news of a clinical hold from the U.S. Food and Drug Administration (FDA). The company announced it...
Published:
Last Updated:
The short interest data have been released for the June 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through...
Published:
Last Updated: